Method and composition to elicit an effective autologous antitumoral immune response in a patient
OwnerEduardo M. Lasalvia-Priscoinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerEduardo M. Lasalvia-Priscoinventor
Estimating the term…
A method and a composition to elicit an effective antitumoral immune response in a patient, specific to his or her own tumor antigens (i.e. an autologous antitumoral immune response), wherein the method preferably elicits an effective autologous antitumoral immune response in a cancer patient. The method includes generating, preserving, and storing specific tumor associated antigens or TAA, and eliciting the autologous antitumoral immune response, at least in part, through a combination of dual vaccines. Specifically, the method provides for both an internal and external vaccine. Additionally, the preparation of an autologous hemoderivative composition for utilization as the an external vaccine is presented, as well as the autologous hemoderivative composition itself.
A method to elicit an effective antitumoral immune response in a patient comprising:
A method to elicit an effective antitumoral immune response in a patient comprising:
A method of preparation of an autologous hemoderivative composition for use in eliciting an effective antitumoral immune response in a patient comprising:
An autologous hemoderivative composition comprising:
Dependencies are inferred from the claim text.